During the past decade, Denver Public Health CRS conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Denver Public Health CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 22 trials, followed by "Centers for Disease Control and Prevention" with 17 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "University of Minnesota" with 3 trials sponsored and "AIDS Clinical Trials Group" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Denver Public Health CRS" #1 collaborator was "US Department of Veterans Affairs" with 10 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator and "Gilead Sciences" with 3 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Denver Public Health CRS" are "HIV Infections" (33 trials), "Tuberculosis" (12 trials), "Cachexia" (3 trials), "HIV Infection" (3 trials) and "Anorexia" (2 trials). Many other conditions were trialed in "Denver Public Health CRS" in a lesser frequency.

Most popular intervention types in "Denver Public Health CRS" are "Drug" (36 trials), "Biological" (7 trials), "Other" (5 trials), "Device" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rifabutin" (6 trials), "Placebo" (4 trials), "Isoniazid" (3 trials), "Megestrol acetate" (3 trials) and "Rifapentine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Denver Public Health CRS" are 54 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Denver Public Health CRS". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Denver Public Health CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Denver Public Health CRS, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".